Absci Corporation

NasdaqGS:ABSI Stock Report

Market Cap: US$530.8m

Absci Management

Management criteria checks 1/4

Absci's CEO is Sean McClain, appointed in Aug 2011, has a tenure of 14.17 years. total yearly compensation is $9.79M, comprised of 6.7% salary and 93.3% bonuses, including company stock and options. directly owns 5.84% of the company’s shares, worth $30.98M. The average tenure of the management team and the board of directors is 2.7 years and 2.5 years respectively.

Key information

Sean McClain

Chief executive officer

US$9.8m

Total compensation

CEO salary percentage6.75%
CEO tenure14.2yrs
CEO ownership5.8%
Management average tenure2.7yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Absci Corporation: ABS-101 Has Both First-Gen And Next-Gen Competitors

Sep 17

Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet?

Jul 19
Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet?

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13

Absci Corporation: Struggling To Live Up To Its AI Promise

Nov 20

Is Absci (NASDAQ:ABSI) A Risky Investment?

Nov 13
Is Absci (NASDAQ:ABSI) A Risky Investment?

Absci: Embryonic Pipeline Looks Expensive Relative To Peers

Oct 29

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 03

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 28

Is Absci (NASDAQ:ABSI) A Risky Investment?

Jun 17
Is Absci (NASDAQ:ABSI) A Risky Investment?

Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula

May 16

Absci: Differentiated Antibody Discovery Play

Feb 27

Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M

Aug 11

Absci teams up to help develop antibody drugs for cancer

Jul 07

Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out

Jan 10

CEO Compensation Analysis

How has Sean McClain's remuneration changed compared to Absci's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$113m

Mar 31 2025n/an/a

-US$107m

Dec 31 2024US$10mUS$660k

-US$103m

Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$109m

Dec 31 2023US$3mUS$620k

-US$111m

Sep 30 2023n/an/a

-US$106m

Jun 30 2023n/an/a

-US$112m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022US$4mUS$600k

-US$105m

Sep 30 2022n/an/a

-US$111m

Jun 30 2022n/an/a

-US$107m

Mar 31 2022n/an/a

-US$121m

Dec 31 2021US$4mUS$505k

-US$103m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$73m

Mar 31 2021n/an/a

-US$48m

Dec 31 2020US$1mUS$260k

-US$49m

Compensation vs Market: Sean's total compensation ($USD9.79M) is above average for companies of similar size in the US market ($USD2.39M).

Compensation vs Earnings: Sean's compensation has increased whilst the company is unprofitable.

CEO

Sean McClain (35 yo)

14.2yrs
Tenure
US$9,786,988
Compensation

Mr. Sean Mcclain is the Founder of Absci Corporation (formerly known as AbSci, LLC) and serves as its Chief Executive Officer since August 2011 and Director since its formation in October 2020. Mr. Mcclain...

Leadership Team

NamePositionTenureCompensationOwnership
Sean McClain
Founder14.2yrsUS$9.79m5.84%
$ 31.0m
Zachariah Jonasson
Chief Business Officer & CFO2.2yrsUS$2.83m0.11%
$ 592.8k
Andreas Busch
Chief Innovation Officer & Member of Scientific Advisory Board3yrsUS$2.64m0.088%
$ 466.7k
Todd Bedrick
Senior VP & Chief Accounting Officer3.3yrsno data0.033%
$ 176.1k
Alexander Khan
VP of Finance & Head of Investor Relations2.6yrsno datano data
Shelby Walker
Chief Legal Officer1.8yrsno datano data
Karin Wierinck
Chief People Officer2.8yrsno datano data
Melissa Patterson
Chief of Staff3.6yrsno datano data
Wen Sha
Chief of Staff3.8yrsno datano data
Christine Lemke
Senior Vice President of Portfolio & Growth Strategy2.7yrsno datano data
Christian Stegmann
Senior Vice President of Drug Creation2.7yrsno datano data
Anders Kassow
Head of Intellectual Propertyless than a yearno datano data
2.7yrs
Average Tenure
51yo
Average Age

Experienced Management: ABSI's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sean McClain
Founder5yrsUS$9.79m5.84%
$ 31.0m
Andreas Busch
Chief Innovation Officer & Member of Scientific Advisory Board1.8yrsUS$2.64m0.088%
$ 466.7k
Mary Szela
Directorless than a yearno datano data
Karen McGinnis
Lead Independent Director5.2yrsUS$261.48k0.016%
$ 84.6k
François van Houten
Independent Director2.3yrsUS$259.25k0.0059%
$ 31.3k
Daniel Rabinovitsj
Independent Director2.9yrsUS$236.02k0.0059%
$ 31.3k
Iain McInnes
Member of Scientific Advisory Boardless than a yearno datano data
David Goldberg
Member Scientific Advisory Boardless than a yearno datano data
Menelas Nicolas Pangalos
Independent Director & Member of Scientific Advisory Board1.8yrsUS$470.25k0.067%
$ 353.1k
Joseph Sirosh
Independent Director3.8yrsUS$211.02k0.0059%
$ 31.3k
Victor Greiff
Member of Scientific Advisory Board2.7yrsno datano data
Hubert Truebel
Member of Scientific Advisory Board2.7yrsno datano data
2.5yrs
Average Tenure
59yo
Average Age

Experienced Board: ABSI's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 11:17
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Absci Corporation is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael RyskinBofA Global Research
Tiago FauthCredit Suisse
Vamil DivanGuggenheim Securities, LLC